Search Results - "Park, HyeJung"

Refine Results
  1. 1
  2. 2

    CNS-accessible Inhibitor of Glucosylceramide Synthase for Substrate Reduction Therapy of Neuronopathic Gaucher Disease by Marshall, John, Sun, Ying, Bangari, Dinesh S, Budman, Eva, Park, Hyejung, Nietupski, Jennifer B, Allaire, Amy, Cromwell, Mary A, Wang, Bing, Grabowski, Gregory A, Leonard, John P, Cheng, Seng H

    Published in Molecular therapy (01-06-2016)
    “…Gaucher disease (GD) is caused by a deficiency of glucocerebrosidase and the consequent lysosomal accumulation of unmetabolized glycolipid substrates…”
    Get full text
    Journal Article
  3. 3

    Substrate reduction therapy using Genz‐667161 reduces levels of pathogenic components in a mouse model of neuronopathic forms of Gaucher disease by Blumenreich, Shani, Yaacobi, Chen, Vardi, Ayelet, Barav, Or B., Vitner, Einat B., Park, Hyejung, Wang, Bing, Cheng, Seng H., Sardi, Sergio P., Futerman, Anthony H.

    Published in Journal of neurochemistry (01-03-2021)
    “…Most lysosomal storage diseases (LSDs) have a significant neurological component, including types 2 and 3 Gaucher disease (neuronal forms of Gaucher disease;…”
    Get full text
    Journal Article
  4. 4

    Quantitative analysis of sphingolipids for lipidomics using triple quadrupole and quadrupole linear ion trap mass spectrometers[S] by Shaner, Rebecca L., Allegood, Jeremy C., Park, Hyejung, Wang, Elaine, Kelly, Samuel, Haynes, Christopher A., Sullards, M. Cameron, Merrill, Alfred H.

    Published in Journal of lipid research (01-08-2009)
    “…Sphingolipids are a highly diverse category of bioactive compounds. This article describes methods that have been validated for the extraction, liquid…”
    Get full text
    Journal Article
  5. 5

    Direct analysis of sialylated or sulfated glycosphingolipids and other polar and neutral lipids using TLC-MS interfaces[S] by Park, Hyejung, Zhou, Ying, Costello, Catherine E.

    Published in Journal of lipid research (01-04-2014)
    “…Gangliosides and sulfatides (STs) are acidic glycosphingolipids (GSLs) that have one or more sialic acids or sulfate substituents, in addition to neutral…”
    Get full text
    Journal Article
  6. 6

    Sphingolipidomics: Methods for the comprehensive analysis of sphingolipids by Haynes, Christopher A., Allegood, Jeremy C., Park, Hyejung, Sullards, M. Cameron

    “…Sphingolipids comprise a highly diverse and complex class of molecules that serve as both structural components of cellular membranes and signaling molecules…”
    Get full text
    Journal Article
  7. 7

    Glucosylceramide synthase inhibition protects against cardiac hypertrophy in chronic kidney disease by Baccam, Gabriel C., Xie, Jian, Jin, Xin, Park, Hyejung, Wang, Bing, Husson, Hervé, Ibraghimov-Beskrovnaya, Oxana, Huang, Chou-Long

    Published in Scientific reports (04-06-2022)
    “…A significant population of patients with chronic kidney disease (CKD) develops cardiac hypertrophy, which can lead to heart failure and sudden cardiac death…”
    Get full text
    Journal Article
  8. 8

    Preclinical pharmacology of glucosylceramide synthase inhibitor venglustat in a GBA-related synucleinopathy model by Viel, Catherine, Clarke, Jennifer, Kayatekin, Can, Richards, Amy M., Chiang, Ming Sum R., Park, Hyejung, Wang, Bing, Shihabuddin, Lamya S., Sardi, S. Pablo

    Published in Scientific reports (22-10-2021)
    “…Mutations in GBA , the gene encoding the lysosomal enzyme glucocerebrosidase (GCase), represent the greatest genetic risk factor for developing…”
    Get full text
    Journal Article
  9. 9

    Human iPSC-derived astrocytes generated from donors with globoid cell leukodystrophy display phenotypes associated with disease by Lieberman, Richard, Cortes, Leslie K, Gao, Grace, Park, Hyejung, Wang, Bing, Jones, Patrick L, Hunter, R. Bridge, Leonard, John P, Barker, Robert H

    Published in PloS one (03-08-2022)
    “…Globoid cell leukodystrophy (Krabbe disease) is a fatal neurodegenerative, demyelinating disease caused by dysfunctional activity of galactosylceramidase…”
    Get full text
    Journal Article
  10. 10

    A novel brain-penetrant oral UGT8 inhibitor decreases in vivo galactosphingolipid biosynthesis in murine Krabbe disease by Zaccariotto, Eva, Cachón-González, María Begoña, Wang, Bing, Lim, Sungtaek, Hirth, Bradford, Park, Hyejung, Fezoui, Malika, Sardi, S.Pablo, Mason, Paul, Barker, Robert H., Cox, Timothy M.

    Published in Biomedicine & pharmacotherapy (01-05-2022)
    “…Krabbe disease is a rare, inherited neurodegenerative disease due to impaired lysosomal β-galactosylceramidase (GALC) activity and formation of neurotoxic…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Association between the presence of delirium during intensive care unit admission and cognitive impairment or psychiatric problems: the Korean ICU National Data Study by Ko, Ryoung-Eun, Kang, Danbee, Park, Hyejung, Cho, Juhee, Suh, Gee Young, Chung, Chi Ryang

    Published in Journal of intensive care (14-02-2022)
    “…Delirium in the intensive care unit (ICU) may be a preventable risk factor for cognitive impairment or psychiatric problems. We aimed to evaluate the…”
    Get full text
    Journal Article
  13. 13

    Sphingosine 1-Phosphate (S1P) Lyase Deficiency Increases Sphingolipid Formation via Recycling at the Expense of de Novo Biosynthesis in Neurons by Hagen-Euteneuer, Nadine, Lütjohann, Dieter, Park, Hyejung, Merrill, Alfred H., van Echten-Deckert, Gerhild

    Published in The Journal of biological chemistry (16-03-2012)
    “…Sphingosine 1-phosphate lyase (S1P lyase) irreversibly cleaves sphingosine 1-phosphate (S1P) in the final step of sphingolipid catabolism. As sphingoid bases…”
    Get full text
    Journal Article
  14. 14

    Sphingolipidomics: a valuable tool for understanding the roles of sphingolipids in biology and disease by Merrill, Alfred H., Stokes, Todd H., Momin, Amin, Park, Hyejung, Portz, Brent J., Kelly, Samuel, Wang, Elaine, Sullards, M. Cameron, Wang, May Dongmei

    Published in Journal of lipid research (01-04-2009)
    “…The sphingolipidome is the portion of the lipidome that encompasses all sphingoid bases and their derivatives. Whereas the most studied sphingoid base is…”
    Get full text
    Journal Article
  15. 15

    Subcellular Origin of Sphingosine 1-Phosphate Is Essential for Its Toxic Effect in Lyase-deficient Neurons by Hagen, Nadine, Van Veldhoven, Paul P., Proia, Richard L., Park, Hyejung, Merrill, Alfred H., van Echten-Deckert, Gerhild

    Published in The Journal of biological chemistry (24-04-2009)
    “…Cerebellar granule cells from sphingosine 1-phosphate (S1P) lyase-deficient mice were used to study the toxicity of this potent sphingolipid metabolite in…”
    Get full text
    Journal Article
  16. 16

    Forecasting the Walking Assistance Rehabilitation Level of Stroke Patients Using Artificial Intelligence by Seo, Kanghyeon, Chung, Bokjin, Panchaseelan, Hamsa Priya, Kim, Taewoo, Park, Hyejung, Oh, Byungmo, Chun, Minho, Won, Sunjae, Kim, Donkyu, Beom, Jaewon, Jeon, Doyoung, Yang, Jihoon

    Published in Diagnostics (Basel) (15-06-2021)
    “…Cerebrovascular accidents (CVA) cause a range of impairments in coordination, such as a spectrum of walking impairments ranging from mild gait imbalance to…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    The galactocerebrosidase enzyme contributes to the maintenance of a functional hematopoietic stem cell niche by Visigalli, Ilaria, Ungari, Silvia, Martino, Sabata, Park, Hyejung, Cesani, Martina, Gentner, Bernhard, Sergi Sergi, Lucia, Orlacchio, Aldo, Naldini, Luigi, Biffi, Alessandra

    Published in Blood (16-09-2010)
    “…The balance between survival and death in many cell types is regulated by small changes in the intracellular content of bioactive sphingolipids. Enzymes that…”
    Get full text
    Journal Article
  20. 20

    Potential role of acid ceramidase in conversion of cytostatic to cytotoxic end-point in pancreatic cancer cells by Morad, Samy A. F., Messner, Maria C., Levin, Jonathan C., Abdelmageed, Noha, Park, Hyejung, Merrill, Alfred H., Cabot, Myles C.

    Published in Cancer chemotherapy and pharmacology (01-03-2013)
    “…Purpose Acid ceramidase (AC) occupies an important place in the control of cancer cell proliferation. We tested the influence of AC inhibition on the effects…”
    Get full text
    Journal Article